Team:Amplino/Home

From 2012e.igem.org

(Difference between revisions)
(Contact Us)
(Amplino project outlines)
Line 10: Line 10:
'''Target Market''': bottom-of-the-pyramid in developing countries
'''Target Market''': bottom-of-the-pyramid in developing countries
-
'''Product''': an affordable, mobile, easy to use, diagnostic tool for malaria
+
'''Challenge''': inadequate Malaria diagnostics, especially for pregnant women
-
'''Business Model''': economically incentify improvement of health in a local community
+
'''Solution''': an affordable, mobile, easy to use, diagnostic device for Malaria
 +
 
 +
'''Business Model''': stimulate entrepreneurship and economically incentify improvement of health in a local community
On this wiki we will present our deliverables for the iGEM Entrepreneurship competition. For more information on our business, please visit the [http://www.amplino.org/ Amplino website].
On this wiki we will present our deliverables for the iGEM Entrepreneurship competition. For more information on our business, please visit the [http://www.amplino.org/ Amplino website].

Revision as of 10:23, 21 October 2012

Amplino project outlines

At Amplino we believe biotech and business combine best when one keeps things simple. Here's a brief overview of our project:

Goal: set up a sustainable biotech business

Vision: make high tech low cost

Mission: make a real impact on the world

Target Market: bottom-of-the-pyramid in developing countries

Challenge: inadequate Malaria diagnostics, especially for pregnant women

Solution: an affordable, mobile, easy to use, diagnostic device for Malaria

Business Model: stimulate entrepreneurship and economically incentify improvement of health in a local community

On this wiki we will present our deliverables for the iGEM Entrepreneurship competition. For more information on our business, please visit the Amplino website.

Contact Us

For any inquiries regarding this iGEM Entrepreneurship project, please contact us at info@amplino.org. Also, take a look at our press page.

Twitter